ClinConnect ClinConnect Logo
Search / Trial NCT03860129

Different Volatile Anaesthetics and the Depth of Long Term ICU Sedation

Launched by RUHR UNIVERSITY OF BOCHUM · Feb 28, 2019

Trial Information

Current as of June 06, 2025

Completed

Keywords

Inhalational Sedation

ClinConnect Summary

The study was approved by the appropriate Institutional Review Board. Thirty ASA II-IV patients, undergoing elective or emergency surgery under general anaesthesia were included and randomized into three equal groups: ISO, SEVO or DES. We used MIRUS, a gas delivery system with a VA reflector, just like AnaConDa, that can be paired with common ICU ventilators. Additionally, MIRUS features the unique ability to maintain the end-tidal concentration (etVA) in target by automatically adjusting the delivery rate. Every 8 hours, the RASS was assessed by the nurse. The log of the EEG-Narcotrend Ind...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Signing of the informed consent document (patient or relatives).
  • Patient age 18 years or older.
  • ASA I-III
  • Exclusion Criteria:
  • ASA IV patients
  • Epidural or spinal analgesia
  • Allergy or known hypersensitivity to any of the study drugs
  • Patients with known or suspected genetic susceptibility to malignant hyperthermia
  • Previous participation in this trial
  • Participation in another clinical trial within 4 weeks prior to selection.
  • Pregnant women

About Ruhr University Of Bochum

Ruhr University Bochum is a prominent research institution located in Germany, renowned for its commitment to advancing medical science and improving healthcare outcomes through innovative clinical research. With a focus on interdisciplinary collaboration, the university actively engages in a range of clinical trials aimed at exploring novel therapeutic approaches and improving patient care. Its dedicated team of researchers and healthcare professionals work together to ensure the highest standards of scientific rigor and ethical conduct, contributing valuable insights to the global medical community.

Locations

Patients applied

0 patients applied

Trial Officials

Thomas Weber, PhD

Principal Investigator

Ruhr University of Bochum, Germany

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials